Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 4Pain, Postoperative 3Pain 2Lung Neoplasms 2Colonic Neoplasms 2Agnosia 2Uterine Cervical Neoplasms 1Spondylitis, Ankylosing 1Pituitary Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Neoplasm, Residual 1Mucositis 1Lymphoma, Follicular 1Inflammation 1Endometrial Neoplasms 1Chronic Pain 1Carcinoma, Non-Small-Cell Lung 1Arthritis, Rheumatoid 1Arthritis, Psoriatic 1Anastomotic Leak 1Adenocarcinoma of Lung 1Acute Pain 1

Interventions

Adalimumab 4Etanercept 3secukinumab 1golimumab 1Vaccines 1Tumor Necrosis Factors 1Tai Ji 1Sulfasalazine 1Standard of Care 1Saline Solution 1Practice Guidelines as Topic 1Methods 1Meloxicam 1Interviews as Topic 1Infliximab 1Herpes Zoster Vaccine 1Exercise 1Etoricoxib 1Educational Status 1Early Intervention, Educational 1Celecoxib 1Anti-Inflammatory Agents, Non-Steroidal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Spondylitis, Ankylosing × Anti-Inflammatory Agents, Non-Steroidal × Clear all
NCT02456363 2015-05-28

Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis

Chung Shan Medical University

Phase 2 Unknown
300 enrolled

Spondylitis, Ankylosing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡